Is BaF3 Bioassay Useful to Identify Patients with Bioinactive Growth Hormone?-Reference-Cited by-同舟云学术

Is BaF3 Bioassay Useful to Identify Patients with Bioinactive Growth Hormone?

Published:2010-01 Issue:8 Volume:23 Page:
ISSN:0334-018X
Container-title:Journal of Pediatric Endocrinology and Metabolism
language:
Short-container-title:

Author:

Pagani Sara,Chaler Eduardo A.,Meazza Cristina,Maceiras Mercedes,Gonzalez Maria Eugenia,Rivarola Marco A.,Cantoni Francesca,Travaglino Paola,Della Croce Lucia,Laarej Kamilia,Bozzola Mauro,Belgorosky Alicia

Publisher

Walter de Gruyter GmbH

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health

Link

https://www.degruyter.com/document/doi/10.1515/jpem.2010.128/pdf

Reference32 articles.

1. GROWTH FAILURE WITH NORMAL SERUM RIA-GH AND LOW SOMATOMEDIN ACTIVITY: SOMATOMEDIN RESTORATION AND GROWTH ACCELERATION AFTER EXOGENOUS GH

2. Short Stature Caused by a Biologically Inactive Mutant Growth Hormone (GH-C53S)

3. Pituitary Dwarfism in a Patient with Circulating Abnormal Growth Hormone Polymers

4. 299 A NEW SYNDROME OF SHORT STATURE DUE TO BIOLOGICALLY INACTIVE BUT IMMUNOREACTIVE GROWTH HORMONE

5. Children with Normal-Variant Short Stature: Treatment with Human Growth Hormone for Six Months

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer;British Journal of Cancer;2016-08-30

2. Development of a Bioassay System for Human Growth Hormone Determination with Close Correlation to Immunoassay;Journal of Clinical Laboratory Analysis;2012-09